PISCATAWAY, N.J. —Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launches of Plerixafor Injection, Baclofen Tablets, Fluvoxamine Maleate ER Capsules, and Olmesartan Hydrochlorothiazide Tablets.
Product | Brand Reference | Strength/Size |
Mozobil® | 24 mg/1.2 mL (20 mg/mL) | |
Lioresal® | 100 ct bottles of 5, 10, & 20 mg | |
Luvox® | 30 ct bottles of 100 & 150 mg | |
Benicar® HCT | 30 & 90 ct bottles of 20 mg/12.5 mg |
These additions reinforce Camber’s commitment to broadening access to affordable, high-quality therapies while continuing to support patients and healthcare professionals nationwide.
